August 25, 2016 11:13 PM ET

Biotechnology

Company Overview of Enanta Pharmaceuticals, Inc.

Executive Profile

Ernst-Günter Afting Ph.D., M.D.

Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee, Enanta Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships
72$168,103

Background

Dr. Ernst-Günter Afting, Ph.D., M.D., serves as a Director of BioMedCredit AG and Olympus Europa GmbH. He has been a Director of Omnicare Clinical Research Inc. since June 1996 and Quikbyte Software, Inc. since September 21, 2009. He has been an Independent Director of Enanta Pharmaceuticals, Inc. since 1995. He serves as Member of Supervisory Board of SuppreMol GmbH. He serves as Director of Prolific Asset Management Limited. He serves as Member of the Supervisory Board ...

Corporate Headquarters

500 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-607-0800
Fax: 617-607-0530

Board Members Memberships

Member of Board of Directors
1995-Present
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education

PhD
University of Freiburg
MD
University of Freiburg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$51,375
Total Calculated Compensation$168,103
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Enanta Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.